Advarra Launches New Technology to Align Patients, Sites, and Sponsors in Clinical Trials
Advarra has announced new technology functionality to its solution, Longboat, an established platform used in more than 70 countries and by nearly 20,000 sites. It now features an online patient portal with a set of engagement tools including a document exchange that enables transparent collaboration between patients, sites, and sponsors or clinical research organizations (CROs) without adding technology burden.
Because the patient portal module is part of the same platform the site uses for essential document collection, training/learning management, study conduct enablement tools, and safety letter viewing and acknowledgement, sites are able to provide a more connected experience for their patients with this workflow.
"We've been listening to sites who are drowning in administrative tasks, repeatedly entering the same information, having to log into multiple systems or feeling out of the loop with direct communication between the sponsor and patient," said Elisa Cascade, chief product officer at Advarra in a press release. "A connected system with site, sponsor, CRO, and patient access provides visibility to all while preserving the site-patient relationship. This transparent collaboration in real time is a win for everyone involved in the study."
Reference
Advarra Launches Next-Generation Technology to Align Patients, Sites, and Sponsors in Clinical Trials. (2023, October 4). Cision PR Newswire.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
